131 related articles for article (PubMed ID: 23345585)
1. Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status.
Enders M; Bartelt U; Knotek F; Bunn K; Strobel S; Dietz K; Enders G
Clin Vaccine Immunol; 2013 Mar; 20(3):420-6. PubMed ID: 23345585
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of fully automated assays for the detection of Rubella IgM and IgG antibodies by the Elecsys(®) immunoassay system.
van Helden J; Grangeot-Keros L; Vauloup-Fellous C; Vleminckx R; Masset F; Revello MG
J Virol Methods; 2014 Apr; 199():108-15. PubMed ID: 24487099
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.
Revello MG; Vauloup-Fellous C; Grangeot-Keros L; van Helden J; Dickstein Y; Lipkin I; Mühlbacher A; Lazzarotto T
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3331-9. PubMed ID: 22850741
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.
Louisirirotchanakul S; Khupulsup K; Akraekthalin S; Chan KP; Saw S; Aw TC; Cho DH; Shin MG; Lim J
J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of switching rubella IgG methodologies to the prenatal public health program in Alberta.
Lai FY; Dover DC; Charlton CL
J Clin Virol; 2016 Oct; 83():43-7. PubMed ID: 27567094
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument.
Medici MC; Martinelli M; Albonetti V; Chezzi C; Dettori G
J Clin Microbiol; 2008 May; 46(5):1847-9. PubMed ID: 18367579
[TBL] [Abstract][Full Text] [Related]
7. [Laboratory evaluation of automated enzyme linked fluorescent assay for detecting serum specific IgG antibodies against rubella virus].
Hou TC; Huang WK; Liu YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 Feb; 29(1):49-56. PubMed ID: 10592786
[TBL] [Abstract][Full Text] [Related]
8. Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results.
Huzly D; Hanselmann I; Neumann-Haefelin D; Panning M
J Clin Virol; 2016 Jan; 74():13-8. PubMed ID: 26638144
[TBL] [Abstract][Full Text] [Related]
9. Multiplex detection of IgM and IgG class antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus using a novel multiplex flow immunoassay.
Binnicker MJ; Jespersen DJ; Harring JA
Clin Vaccine Immunol; 2010 Nov; 17(11):1734-8. PubMed ID: 20861325
[TBL] [Abstract][Full Text] [Related]
10. A qualitative and quantitative comparison of two rubella virus-specific IgG antibody immunoassays.
Greenwood NP; Ovsyannikova IG; Vierkant RA; O'Byrne MM; Poland GA
Viral Immunol; 2010 Aug; 23(4):353-7. PubMed ID: 20712479
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the LIAISON®XL and ARCHITECT IgG, IgM, and IgG avidity assays for the diagnosis of Toxoplasma, cytomegalovirus, and rubella virus infections.
Genco F; Sarasini A; Parea M; Prestia M; Scudeller L; Meroni V
New Microbiol; 2019 Apr; 42(2):88-93. PubMed ID: 30994178
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two commercial ELISA kits for detection of rubella specific IgM in suspected congenital rubella syndrome cases and rubella IgG antibodies in a serosurvey of pregnant women.
Viswanathan R; George S; Murhekar MV; Abraham AM; Singh MP; Jadhav SM; Nag V; Naik S; Raut C; Munivenkatappa A; Gupta M; Jagtap V; Kaduskar O; Gupta N; Sapkal GN
Diagn Microbiol Infect Dis; 2019 Jul; 94(3):243-247. PubMed ID: 30782464
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three immunoassays for determination of immunity to rubella virus in healthcare workers.
Jo SY; Shin KH; Lee SM; Jeong EY; Lee HJ; Chang CL
J Immunol Methods; 2018 Dec; 463():84-88. PubMed ID: 30237054
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.
Dimech W; Panagiotopoulos L; Francis B; Laven N; Marler J; Dickeson D; Panayotou T; Wilson K; Wootten R; Dax EM
J Clin Microbiol; 2008 Jun; 46(6):1955-60. PubMed ID: 18434559
[TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of the Elecsys® anti-HCV II assay for the diagnosis of hepatitis C virus infection.
Esteban JI; van Helden J; Alborino F; Bürgisser P; Cellerai C; Pantaleo G; Eiras A; Rodriguez MI; Ghisetti V; Gleich M; Imdahl R; Kaiser C; Möller P; Wetlitzky O; Segovia M; Schennach H; Mühlbacher A
J Med Virol; 2013 Aug; 85(8):1362-8. PubMed ID: 23765774
[TBL] [Abstract][Full Text] [Related]
16. Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.
Dimech W; Arachchi N; Cai J; Sahin T; Wilson K
Clin Vaccine Immunol; 2013 Feb; 20(2):255-61. PubMed ID: 23254301
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
[TBL] [Abstract][Full Text] [Related]
19. [Demonstration of Rubella-specific IgG and IgM antibody (sub) classes using the enzyme immunoassay (EIA)].
Doerr HW; Fleischer G; Wiesmann M
Immun Infekt; 1984 Feb; 12(1):21-8. PubMed ID: 6398271
[TBL] [Abstract][Full Text] [Related]
20. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.
Mitchell LA; Ho MK; Rogers JE; Tingle AJ; Marusyk RG; Weber JM; Duclos P; Tepper ML; Lacroix M; Zrein M
J Clin Microbiol; 1996 Sep; 34(9):2210-8. PubMed ID: 8862587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
